Kazuki Sekitani
Director/Board Member bei EPS HOLDINGS, INC.
Profil
Kazuki Sekitani is currently the Executive Vice Chairman at EPS Holdings, Inc. and an Independent Outside Director at GNI Group Ltd.
He previously worked as a Director at Kaken Pharmaceutical Co., Ltd.
and as a Director at EPS Global Research, Inc. Mr. Sekitani obtained his undergraduate degree from the University of Tokyo in 1980.
Aktive Positionen von Kazuki Sekitani
| Unternehmen | Position | Beginn |
|---|---|---|
| EPS HOLDINGS, INC. | Director/Board Member | 01.04.2011 |
| GNI GROUP LTD. | Director/Board Member | 30.03.2023 |
Ehemalige bekannte Positionen von Kazuki Sekitani
| Unternehmen | Position | Ende |
|---|---|---|
| KAKEN PHARMACEUTICAL CO., LTD. | Director/Board Member | - |
EPS Global Research, Inc.
 EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Director/Board Member | - |
Ausbildung von Kazuki Sekitani
| University of Tokyo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KAKEN PHARMACEUTICAL CO., LTD. | Health Technology |
| GNI GROUP LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
EPS Holdings, Inc.
 EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Commercial Services |
